SOPHARMA AD: Decision on additional contribution to the capital of Sopharma Rus OOO

2024-12-20 12:15

publikacja
2024-12-20 12:15

Spis treści:

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
SFA_Add_Installment_Sopharma_Rus_20122024_espi.pdf (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		147	/	2024
Date of issue:	2024-12-20
Short name of the issuer
SOPHARMA AD
Subject
Decision on additional contribution to the capital of Sopharma Rus OOO
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria, December 20, 2024 – In accordance with the requirements of Art. 100t of the LPOS, Sopharma AD (SFA: Bulgarian Stock Exchange AD, SPH: Warsaw Stock Exchange) hereby informs that in order to ensure operational opportunities for growth and increase sales on the traditional markets where the Company operates, the Board of Directors has decided to make an additional contribution to its subsidiary “Sopharma Rus” OOO in the amount of EUR 12.3 million, not increasing the capital.
Annexes
File			Description
SFA_Add_Installment_Sopharma_Rus_20122024_espi.pdfSFA_Add_Installment_Sopharma_Rus_20122024_espi.pdf			Decision on additional contribution to the capital of Sopharma Rus OOO

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2024-12-20	Ognian Donev	Executive director

Ważne linki